Sg Americas Securities, LLC Bio Xcel Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$9.03 - $21.55 $392,516 - $936,735	43,468 New	43,468 $574,000
Q4 2021 Feb 07, 2022	SELL	$20.12 - $35.09 $137,258 - $239,383	-6,822 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$23.84 - $32.03 $162,636 - $218,508	6,822 New	6,822 $207,000
Q2 2021 Aug 12, 2021	SELL	$29.06 - $38.83 $71,342 - $95,327	-2,455 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$39.04 - $64.6 $95,843 - $158,593	2,455 New	2,455 $106,000
Q4 2020 Feb 04, 2021	SELL	$42.46 - $56.58 $675,878 - $900,640	-15,918 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$37.44 - $64.63 $595,969 - $1.03 Million	15,918 New	15,918 $690,000

3.1M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $5.32M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.